knowledge -WSS

knowledge

author：comprehensive 2025-10-01 14:16:09 - browse：89

Hyundai Kia Recall — FILE - A line of 2022 Santa Fe SUV's sit outside a Hyundai dealership Sunday, Sept. 12, 2021, in Littleton, Colo. In documents posted Thursday, Aug. 3, 2023, Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires. (AP Photo/David Zalubowski, File)The Associated Press

DETROIT -- Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires.

The affiliated Korean automakers are recalling the vehicles and also are telling owners to park them away from structures until repairs are made.

The recalls cover certain 2023 and 2024 Hyundai Palisades, as well some 2023 Tucson, Sonata, Elantra and Kona vehicles. Affected Kias include the 2023 Soul and Sportage as well as some 2023 and 2024 Seltos vehicles.

The companies say in documents posted Thursday by U.S. safety regulators that a capacitor on a circuit board in the oil pump assembly for the transmission may have been damaged by the supplier during manufacturing. That can cause a short-circuit and increase the risk of a fire.

Kia says it has six reports of melting components but no fires or injuries. Hyundai says it has confirmed four “thermal incidents” and no injuries.

Dealers will inspect and replace the oil pump controller if necessary. Hyundai owners will be notified by letter on Sept. 25. Kia will notify owners starting Sept. 28.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： UnitedHealth argues against case alleging wrongful AI care denials

entertainment

WSS

Bispecific antibodies are next new thing in cancer immunotherapy

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

FDA poised to publish guidelines for clinical trial diversity

Bird flu surveillance in wastewater gets boost from consortium

Xenotransplantation trials will require adjusting expectations, experts say

Senate panel passes drug pricing bills, but drops one PBM reform

entertainment

knowledge

focus

Moonlake's readout produced a cash windfall. Risks remain

Listen: More tumult at BIO & coercive care for sickle cell patients

United colonoscopy coverage change 'may cost lives,' doctors say

Fentanyl is making it harder to start addiction treatment

Anesthesiologist group: stop taking Ozempic before surgery

Fentanyl is making it harder to start addiction treatment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Drug repurposing or repositioning? The language matters

Digital health: a case of mistaken identity

leisure time

H5N1 bird flu outbreak: Second human case reported, in Michigan

Biogen nominates mother of director’s child to replace him on board

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Timeline: Key moments in fight for gay rights

As a primary care physician, here's how I hope to partner with AI

entertainment

entertainment

focus

knowledge